Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
India Glycols Limited ( (IN:INDIAGLYCO) ) has issued an announcement.
India Glycols Limited has updated exchanges on the progress of its Scheme of Arrangement involving the demerger of businesses into Ennature Biopharma Limited and IGL Spirits Limited, a corporate restructuring being overseen by the National Company Law Tribunal (NCLT) at the Allahabad Bench in Prayagraj. The latest NCLT session scheduled on 21 May 2026 could not take up the matter due to lack of time, delaying further hearings and leaving the next date to be notified, which may extend timelines for completing the restructuring and adds short-term uncertainty for stakeholders tracking the scheme’s implementation.
The company has indicated it will inform markets of any subsequent developments in the NCLT process as they arise, underscoring ongoing regulatory oversight of the demerger. While no adverse order has been passed, the procedural delay means investors and other stakeholders must wait longer for clarity on the final approval and execution of the planned reorganisation.
More about India Glycols Limited
India Glycols Limited operates in the chemicals and allied products sector, with interests in specialty chemicals, bio-based ingredients and related businesses, and has structured its operations through subsidiary entities such as Ennature Biopharma Limited and IGL Spirits Limited to focus on distinct product and market segments.
Average Trading Volume: 7,724
Technical Sentiment Signal: Strong Buy
Current Market Cap: 66.59B INR
For detailed information about INDIAGLYCO stock, go to TipRanks’ Stock Analysis page.